Skip to search formSkip to main contentSkip to account menu

BB 1101

Known as: BB-1101 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (4)

Benzyl CompoundsDexamethasoneProtease InhibitorsSuccinates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Novel promising stroke therapy: new pharmacological and laser stimulation of brain clearance
Stroke and traumatic brain injury are often associated with formation of brain edema, which is a potentially fatal pathological… 
2004
2004
Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration
2004
2004
Cerebral ischemia, matrix metalloproteinases, and TNF-alpha: MMP inhibitors may act not exclusively by reducing MMP activity.
To the Editor: We thank Drs Pfefferkorn and Rosenberg for their enlightening paper1 on matrix metalloproteinases (MMPs) after… 
Highly Cited
2002
Highly Cited
2002
Upregulation of TACE/ADAM17 after Ischemic Preconditioning is Involved in Brain Tolerance
A short ischemic event (ischemic preconditioning [IPC]) can result in a subsequent resistance to severe ischemic injury (ischemic… 
1999
1999
The matrix metalloproteinase inhibitor BB‐1101 prevents experimental autoimmune uveoretinitis (EAU)
EAU is characterized by breakdown of the blood–retinal barrier and extravasation of leucocytes into retinal tissue leading to… 
1999
1999
Effect of a Matrix Metalloproteinase Inhibitor (BB‐1101) on Nerve Regeneration
Guillain-Barré syndrome (GBS) is an acute monophasic autoimmune inflammatory disease of the peripheral nervous system (PNS). 1… 
1998
1998
Differential regulation of brain and plasma TNFα a produced after endotoxin shock
FROM undetectable basal levels, TNFα is produced in the hypothalamus of rats challenged with a systemic low profile endotoxin… 
1998
1998
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
Matrix metalloproteinases (MMPs) are associated with neuroinflammatory diseases, and blood-brain barrier damage is a… 
1997
1997
Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNFα processing
Objective and Design: The effects of two hydroxamate inhibitors of metalloproteinase and tumor necrosis factor α (TNF… 
Highly Cited
1996
Highly Cited
1996
Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)